Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker ▴	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth	Diluted EPS
EMMA	Emmaus Life Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$12.45M	-$7.49M	-60.2%	n/a	-25.2%	-$0.12
ENLV	Enlivex Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	$1.24B	n/a	63.9%	n/a	$25.48
ENSC	Ensysce Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$5.07M	-$10.18M	-200.8%	-316.6%	-2.8%	-$3.98
ENTA	Enanta Pharmaceuticals Inc Manufacturing · Year ended 2025-09-30 · USD	$65.32M	-$81.89M	-125.4%	-126.5%	-3.4%	-$3.84
ENVB	Enveric Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$8.77M	n/a	-210.0%	n/a	-$36.24
EOCN	Galmed Pharmaceuticals Ltd. Manufacturing · Year ended 2025-12-31 · USD	n/a	$6.90M	n/a	43.7%	n/a	$2.39
EOLS	Evolus, Inc. Manufacturing · Year ended 2025-12-31 · USD	$297.18M	-$51.64M	-17.4%	n/a	11.6%	-$0.80
EPRX	Eupraxia Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$38.58M	n/a	-47.0%	n/a	-$1.03
EQ	Equillium, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$22.40M	n/a	-78.3%	n/a	-$0.39
ERAS	Erasca, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$124.55M	n/a	-38.3%	n/a	-$0.44
ERNA	Ernexa Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$14.08M	n/a	-586.6%	n/a	-$2.24
ETON	Eton Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$79.95M	-$4.60M	-5.8%	-17.6%	104.9%	n/a
ETST	Earth Science Tech, Inc. Manufacturing · Year ended 2026-03-31 · USD	$35.70M	$3.63M	10.2%	51.8%	7.8%	$0.012
EVFM	Evofem Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$20.18M	$391.0K	1.9%	n/a	4.2%	$0.00
EVMN	Evommune, Inc. Manufacturing · Year ended 2025-12-31 · USD	$13.00M	-$68.87M	-529.8%	-33.5%	85.7%	-$11.22
EWTX	Edgewise Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$167.79M	n/a	-32.1%	n/a	-$1.63
FBIO	Fortress Biotech, Inc. Manufacturing · Year ended 2025-12-31 · USD	$63.26M	$6.82M	10.8%	13.7%	9.7%	-$0.07
FBLG	FibroBiologics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$18.65M	n/a	-302.9%	n/a	-$0.42
FHTX	Foghorn Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$30.91M	-$74.28M	-240.3%	n/a	36.8%	-$1.18
FLNA	Filana Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$90.97M	n/a	-122.3%	n/a	-$1.88
FTH	Faeth Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$21.09M	n/a	-113.4%	n/a	-$16.72
FULC	Fulcrum Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$74.88M	n/a	-21.5%	-100.0%	-$1.18
GALT	Galectin Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$30.84M	n/a	n/a	n/a	-$0.48
GANX	Gain Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$20.16M	n/a	-108.6%	n/a	-$0.61
GCAN	Trafalgar International, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$331.6K	n/a	n/a	n/a	$0.00

Rows per page: 2550 100